Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have Failed
{{output}}
Background: In the DELIVER trial, eptinezumab administration was associated with sustained reductions in headache frequency and migraine-related impact in participants for whom previous preventive treatments have failed. This pos... ...
